Merck KGaA, Darmstadt, Germany hosts the 3rd Compound Challenge, a competition to identify the best submitted synthetic route for a given small molecule as determined by:
- number of synthesis steps
- obtained yield
- achieved purity
- feasibility of subsequent steps not performed
Anyone from around the world can register for the competition. Registration is by February 26th, 2021. After the registration period, those successfully registered for the challenge receive the structure of a small molecule and then have 96 hours to submit their proposed synthesis route. All the submitted routes are anonymized, and all registered participants are assigned to evaluate part of these anonymized routes in a randomized manner. Based on the participants evaluation, we then select the top 10 best evaluated routes to participate in the synthesis phase of the challenge. The selected routes will be tested in a wet lab and the participants with the best route, as determined by the above criteria, win a prize of EUR 10,000.
Who can participate?
Anyone from around the world may participate, as an individual or in a team where not prohibited by local or country law. Individuals or Teams may choose to opt-out of receiving the prize money if required to do so by their Organization. This challenge is not open to Health Care Professionals.
How does it work?
- Application by “Registration Form” and accepting terms and conditions.
- Submit your own (single applicant) or your team’s (team application) completed registration by filling out the “Registration Form”, and submitting to Open.Innovation@emdgroup.com before 23:59 (CET) February 26th, 2021.
- We provide the structure of a small molecule to all registered participants on March 15, 2021 at 09:00 (CET).
- Participants have 96 hrs. to generate and submit a synthesis route to the e-mail address provided by us.
- All obtained synthesis routes are anonymized, and each participant is assigned to evaluate several of these anonymized routes.
- We select the top 10 best evaluated routes, to be tested in an actual chemical synthesis with a CRO of Mour choice.
- The winner, based on the above criteria, will receive a EUR 10,000 prize.
Merck KGaA, Darmstadt, Germany will not attempt to commercialize any of the submitted synthetic routes.